Phosphodiesterase-5 inhibitors for premature ejaculation: a systematic review and meta-analysis.

[1]  Jonathan L Rees,et al.  Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial]. , 2015, Health technology assessment.

[2]  A. Otunctemur,et al.  Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase‐5 inhibitors in the treatment of premature ejaculation , 2015, Andrologia.

[3]  E. Kaltenthaler,et al.  Interventions to treat premature ejaculation: a systematic review short report. , 2015, Health technology assessment.

[4]  C. Liang,et al.  Combination of Sertraline and Sildenafil versus Sertraline Monotherapy in the Treatment of Acquired Premature Ejaculation without Concomitant Diseases , 2014 .

[5]  W. Hellstrom,et al.  An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. , 2014, The journal of sexual medicine.

[6]  W. Hellstrom,et al.  An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation , 2014, Sexual medicine.

[7]  S. Cho,et al.  Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study. , 2013, The journal of sexual medicine.

[8]  M. Bastawisy,et al.  On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial , 2013, Arab journal of urology.

[9]  R. Miano,et al.  Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? a systematic review and meta-analysis. , 2012, The journal of sexual medicine.

[10]  E. Jannini,et al.  The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. , 2011, The journal of sexual medicine.

[11]  Cara Liday,et al.  The Comparison of Combination SSRI and PDE-5 Inhibitor Therapy to SSRI Monotherapy in Men with Premature Ejaculation , 2011, The Annals of pharmacotherapy.

[12]  F. Montorsi,et al.  Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. , 2010, European urology.

[13]  David Moher,et al.  CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials , 2010, PLoS medicine.

[14]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[15]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[16]  A. Aversa,et al.  Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation , 2009, International Journal of Impotence Research.

[17]  T. H. Klotz,et al.  Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study , 2009, Andrologia.

[18]  C. McMahon.  Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies--part II--study design, outcome measures, data analysis, and reporting. , 2008, The journal of sexual medicine.

[19]  W. Hellstrom,et al.  An evidence‐based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation , 2008, BJU international.

[20]  W. Hellstrom,et al.  An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. , 2008, The journal of sexual medicine.

[21]  M. Srougi,et al.  Tadalafil and Fluoxetine in Premature Ejaculation: Prospective, Randomized, Double-Blind, Placebo-Controlled Study , 2008, Urologia Internationalis.

[22]  A. Zwinderman,et al.  Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy. , 2008, The journal of sexual medicine.

[23]  H. Matzkin,et al.  The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data. , 2007, European urology.

[24]  H. Yarmohammadi,et al.  Effect of Fluoxetine Alone and in Combination with Sildenafil in Patients with Premature Ejaculation , 2007, Urologia Internationalis.

[25]  D. Patrick,et al.  ORIGINAL RESEARCH—EJACULATORY DISORDERS: Interrelationships Among Measures of Premature Ejaculation: The Central Role of Perceived Control , 2007 .

[26]  S. Minhas,et al.  Can sildenafil treat primary premature ejaculation? A prospective clinical study , 2007, International journal of urology : official journal of the Japanese Urological Association.

[27]  C. McMahon,et al.  Efficacy of type‐5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review , 2006, BJU international.

[28]  A. Tuncel,et al.  Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation. , 2006, Urology.

[29]  J. Harris,et al.  Recommendations for the management of premature ejaculation: BASHH Special Interest Group for Sexual Dysfunction , 2006, International journal of STD & AIDS.

[30]  Yin-fa Han,et al.  [Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation]. , 2005, Zhonghua nan ke xue = National journal of andrology.

[31]  B. Stuckey,et al.  Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. , 2005, The journal of sexual medicine.

[32]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[33]  F. Montorsi,et al.  A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. , 2002, The Journal of urology.

[34]  J. Harten.  Clinical Pharmacokinetics of Selective Serotonin Reuptake Inhibitors , 1993 .

[35]  J. Chakraborty,et al.  Experimental Unilateral Torsion of the Spermatic Cord in Guinea Pigs Effects on the Contralateral Testis , 1982 .

[36]  J. Tetzlaff,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2014 .

[37]  A. Lenzi,et al.  Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation? , 2011, International Journal of Impotence Research.

[38]  K. Jamrozik,et al.  Male erectile dysfunction: its prevalence in Western australia and associated sociodemographic factors. , 2008, The journal of sexual medicine.

[39]  C. Hiemke,et al.  Pharmacokinetics of selective serotonin reuptake inhibitors. , 2000, Pharmacology & therapeutics.

[40]  M. L. Godpodinoff,et al.  Premature ejaculation: clinical subgroups and etiology. , 1989, Journal of sex & marital therapy.